Neuronetics, Inc. (STIM): Capital Expenditures
$801.0K
Year ended 2025-12-31
$944.0K
Trailing 12 months to 2026-06-30
-37.4%
3-year compound annual growth
+1.9%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $801.0K | -45.4% | 2026-03-17, From 2025-01-01 |
| 2024-12-31 | $1.47M | -38.1% | 2026-03-17, From 2024-01-01 |
| 2023-12-31 | $2.37M | -27.5% | 2026-03-17, From 2023-01-01 |
| 2022-12-31 | $3.27M | +38.9% | 2025-03-27, From 2022-01-01 |
| 2021-12-31 | $2.35M | +222.3% | 2024-03-08, From 2021-01-01 |
| 2020-12-31 | $730.0K | -10.2% | 2023-03-07, From 2020-01-01 |
| 2019-12-31 | $813.0K | -19.6% | 2022-03-08, From 2019-01-01 |
| 2018-12-31 | $1.01M | +70.2% | 2021-03-02, From 2018-01-01 |
| 2017-12-31 | $594.0K | +83.3% | 2020-03-03, From 2017-01-01 |
| 2016-12-31 | $324.0K | n/a | 2019-03-05, From 2016-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | 2025-12-31 | $801.0K | -45.4% |
| InfuSystem Holdings, Inc (INFU) | 2025-12-31 | $560.0K | -48.7% |
| Xtant Medical Holdings, Inc. (XTNT) | 2025-12-31 | $2.38M | -42.1% |
| Heartflow, Inc. (HTFL) | 2025-12-31 | $5.03M | +15.3% |
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $4.20M | +10.5% |
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $6.83M | -11.7% |
| SI-BONE, Inc. (SIBN) | 2025-12-31 | $8.41M | -19.8% |
| Treace Medical Concepts, Inc. (TMCI) | 2025-12-31 | $13.52M | +16.6% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $5.30M | +56.0% |
Compare STIM, INFU, XTNT, HTFL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗